Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Stryker Reaches New 52-Week High (SYK)
The Street
Tuesday, January 15, 2013 - 11:07pm
tags:
Stryker, 52 week high, stock
Luminex Receives FDA Clearance for First Comprehensive Gastrointestinal Pathogen Infectious Disease Diagnostic in the United States
Yahoo/PRNewswire
Tuesday, January 15, 2013 - 10:57pm
tags:
Luminex, FDA, regulatory, devices, gastrointestinal
BD PhaSeal™ System Receives Clearance from FDA Under Newly Created ONB Product Code
Yahoo/PRNewswire
Tuesday, January 15, 2013 - 10:57pm
tags:
BD PhaSeal, FDA, regulatory, devices, Becton Dickinson
AtriCure Announces Commencement of Public Offering of Common Stock
Yahoo/BusinessWire
Tuesday, January 15, 2013 - 10:56pm
tags:
ArtiCure, stock, public offering
Becton Dickinson Reaches New 52-Week High (BDX)
The Street
Tuesday, January 15, 2013 - 10:54pm
tags:
Becton Dickinson, 52 week high, stock
New AZ chief sends top execs packing in management shuffle
Fierce Pharma
Tuesday, January 15, 2013 - 12:05pm
tags:
pharma execs, AstraZeneca, Pascal Soriot
This Is No Vioxx 2.0
Motley Fool
Tuesday, January 15, 2013 - 11:57am
tags:
Vioxx, Tredaptive, Merck
Unigene Welcomes FDA Advisory Committee Review of Salmon Calcitonin
Yahoo
Tuesday, January 15, 2013 - 11:55am
tags:
Unigene, FDA, advisory panels, calcitonin salmon, osteoporosis
Teva Pharmaceuticals - Food For Thought
Seeking Alpha
Tuesday, January 15, 2013 - 11:52am
tags:
Teva, Pfizer
Forest Labs takes 3Q loss on payments, lower sales
Yahoo/AP
Tuesday, January 15, 2013 - 11:51am
tags:
Forest Labs, earnings
Arena Pharma Investors: DEA, Hedge Funds Conspiring To Destroy Belviq
TheStreet.com
Tuesday, January 15, 2013 - 11:50am
tags:
Arena Pharmaceuticals, DEA, Belviq
FDA OKs Neuralstem Trial Treating Spinal Cord Injuries With Stem Cells
Motley Fool
Tuesday, January 15, 2013 - 11:44am
tags:
Neuralstem, spinal cord injury, stem cells, NSI-566
Santarus Stock Pops To 8-Year High On Drug Approval
Investors.com
Tuesday, January 15, 2013 - 11:43am
tags:
FDA, ulcerative colitis, Santarus, Uceris
Sangamo BioSciences: A Biotech Not To Be Shorted
Seeking Alpha
Tuesday, January 15, 2013 - 11:41am
tags:
Sangamo BioSciences
Anacor Readies Results From Pivotal Study of Toenail Fungus Drug
TheStreet.com
Tuesday, January 15, 2013 - 11:40am
tags:
Anacor, Onychomycosis, Tavaborole
Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
Seeking Alpha
Tuesday, January 15, 2013 - 11:39am
tags:
tivantinib, Arqule, colorectal cancer, Daiichi Sankyo
InterMune will sell $85M in debt and 12.5M shares of its stock to fund studies, marketing
Yahoo/AP
Tuesday, January 15, 2013 - 11:38am
tags:
InterMune, stock offering
Analysis: Drug industry bets on new blockbusters in 2013
Reuters
Tuesday, January 15, 2013 - 11:37am
tags:
Roche, GlaxoSmithKline, Eli Lilly, Biogen Idec, Gilead Sciences, Novo Nordisk
Pfizer’s Possible Unit Shuffle Triggers Breakup Concern
Bloomberg
Tuesday, January 15, 2013 - 11:36am
tags:
Pfizer
Roche And AstraZeneca Overhaul R&D Operations
Pharmalot
Tuesday, January 15, 2013 - 11:35am
tags:
Roche, AstraZeneca, R&D

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.